drugset / Trial / NCT01003483

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

NCT01003483

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the influence of Orlistat and Metformin on obesity treatment in obese PCOS women.

Timeline

Start
2008-12-01
Primary completion
2009-08
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Orlistat Small molecule 120 mg

Indications